No Data
No Data
Express News | CERo Therapeutics Received Notice Of Allowance For US Patent Titled "CHIMERIC TIM4 RECEPTORS AND USES THEREOF (FOR THE TREATMENT OF CANCER)"
CERo Therapeutics Partners With University Of California Davis For Manufacturing Of CER-1236 In Upcoming Phase 1 AML Trial; First Patient Dosing Anticipated H1 2025
Express News | Cero Therapeutics Holdings Inc - on Track for First Patient Dosing in H1 2025
Cero Therapeutics Announces Progress in Initiation of Phase 1 Trial
Express News | Cero Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement With Contract Research Organization Cellcarta to Manage Translational Assays
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement With Contract Research Organization CellCarta to Manage Translational Assays